Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 78 M70 M68 M70 M76 M73 M 287 M Research & development —————— — Operating income 68 M-7 M-25 M-46 M62 M6 M -3 M Non-Operating Income, Total —————— — Interest expense, net of interest capitalized 6 M6 M6 M6 M6 M6 M 24 M Non-Operating Income, excl. Interest Expenses —————— — Unusual income/expense —————— — Pretax income 72 M-6 M-24 M-46 M63 M5 M -2 M Equity in earnings —————— — Taxes 21 M-1 M-4 M-13 M30 M1 M 14 M Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 51 M-5 M-20 M-33 M33 M4 M -16 M Discontinued operations —————— — Net income 51 M-5 M-20 M-33 M33 M4 M -16 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 51 M-5 M-20 M-33 M33 M4 M -16 M Basic earnings per share (Basic EPS) 1.37-0.14-0.53-0.890.880.1 -0.44 Diluted earnings per share (Diluted EPS) 1.35-0.14-0.53-0.870.880.1 -0.42 Average basic shares outstanding 38 M38 M38 M38 M38 M38 M — Diluted shares outstanding 38 M38 M38 M38 M38 M39 M — EBITDA 1.63 B1.44 B1.41 B1.46 B1.67 B1.49 B 6.03 B EBIT 1.62 B1.43 B1.4 B1.45 B1.66 B1.48 B 5.98 B Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 11 M11 M11 M12 M11 M10 M 44 M